Cassava Sciences
SAVA
#9271
Rank
A$0.16 B
Marketcap
A$3.35
Share price
12.26%
Change (1 day)
4.41%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-12.52%
2024 -A$0.21 Billion34.28%
2023 -A$0.15 Billion32.41%
2022 -A$0.12 Billion143.46%
2021 -A$46.24 Million383.92%
2020 -A$9.56 Million36.96%
2019 -A$6.98 Million-25.56%
2018 -A$9.38 Million-44.25%
2017 -A$16.81 Million-20.11%
2016 -A$21.04 Million5.32%
2015 -A$19.98 Million14.23%
2014 -A$17.49 Million-139.64%
2013 A$44.11 M
2010 -A$19.28 Million102.87%
2009 -A$9.51 Million-177.52%
2008 A$12.25 M-14.32%
2007 A$14.3 M-1942.21%
2006 -A$0.78 Million
2004 -A$54.81 Million75.1%
2003 -A$31.3 Million
2001 -A$24.36 Million20.49%
2000 -A$20.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA